This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Hyperuricaemia and hyperlipidaemia

Authoring team

  • a high proportion of patients with hypertriglyceridaemia (approximately 50%) also have hyperuricaemia
    • the reason for the association is unclear because there is no causal relationship between hypertriglyceridaemia and gout - there are however common associations between the two pathologies (e.g. obesity and high alcohol consumption)
    • lipid lowering medication, in general, does not affect urate levels
      • the exceptions to this are treatment with nicotinic acid which results in raised urate levels, and, treatment with fenofibate which results in lower urate levels. The urate lowering effect of fenofibrate is via an independent uricosuric effect and not secondary to lipid lowering

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.